The LOCATE trial was a prospective, U.S., multicenter, open-label study investigating the impact of 18 F-fluciclovine PET/CT imaging on patient management of biochemically recurrent prostate cancer ...
DURHAM, N.C. -- A new multi-institutional study led by investigators at Duke University Medical Center indicates that a diagnostic scan may help localize recurrent prostate disease in men who have had ...
Using an engineered common cold virus, UCLA researchers delivered a genetic payload to prostate cancer cells that allowed them, using Positron Emission Tomography (PET), to locate the diseased cells ...
A transrectal ultrasound (TRUS) of the prostate may also be called a prostate sonogram or endorectal ultrasound. A doctor usually performs a TRUS to help diagnose prostate cancer or detect prostate ...
BURLINGTON, Mass. & OXFORD, England--(BUSINESS WIRE)--Blue Earth Diagnostics, a molecular imaging diagnostics company, today announced the upcoming presentation of additional analyses from the LOCATE ...
A prostate nodule is a firm, knuckle-like area on the prostate gland that can occur for various reasons, including cancer, inflammation, or prostate stones. Diagnosis involves a digital rectal exam ...
Prostate cancer, one of the most common cancers affecting men, is back in the spotlight after a new national report revealed an alarming surge in cases across the United States over the past decade. A ...
Most people with prostate cancer won’t die from it. But it still kills more American men than any type of cancer except lung cancer, because prostate cancer is more common. Prostate cancer needs ...
While most prostate cancers grow slowly, some may classify as aggressive prostate cancers based on stage and grade. Prostate cancers mostly consist of adenocarcinomas, which develop within the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback